|
PLEKHB2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.745800E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.308800E-01 |
| Normal-vs-Stage2 |
5.226800E-01 |
| Normal-vs-Stage3 |
9.363800E-01 |
| Normal-vs-Stage4 |
9.916200E-01 |
| Stage1-vs-Stage2 |
7.027600E-01 |
| Stage1-vs-Stage3 |
5.260200E-01 |
| Stage1-vs-Stage4 |
7.097200E-01 |
| Stage2-vs-Stage3 |
4.688600E-01 |
| Stage2-vs-Stage4 |
5.576800E-01 |
| Stage3-vs-Stage4 |
9.517800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.457800E-01 |
| Normal-vs-AfricanAmerican |
8.401800E-02 |
| Normal-vs-Asian |
8.580400E-01 |
| Caucasian-vs-AfricanAmerican |
1.191440E-01 |
| Caucasian-vs-Asian |
7.228000E-01 |
| AfricanAmerican-vs-Asian |
1.362970E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.746000E-01 |
| Normal-vs-Female |
5.683200E-01 |
| Male-vs-Female |
5.105600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.944000E-01 |
| Normal-vs-Age(41-60Yrs) |
7.925000E-01 |
| Normal-vs-Age(61-80Yrs) |
5.802400E-01 |
| Normal-vs-Age(81-100Yrs) |
7.741400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.873390E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.085400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.311600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.617600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.268000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.970000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.319200E-01 |
| Classical-VS-Follicular |
9.770200E-01 |
| Classical-VS-Other |
4.438400E-02 |
| Classical-VS-Normal |
4.778000E-01 |
| Tall-VS-Follicular |
8.600600E-01 |
| Tall-VS-Other |
4.731700E-02 |
| Tall-VS-Normal |
7.959200E-01 |
| Follicular-VS-Other |
1.123160E-01 |
| Follicular-VS-Normal |
6.293800E-01 |
| Other-VS-Normal |
3.441800E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.117600E-01 |
| Normal-vs-N1 |
1.749590E-01 |
| N0-vs-N1 |
1.151410E-01 |
|
|
